Zhao R - Search Results

1

Optimization of solid-phase extraction (SPE) in the preparation of [¹⁸F]D3FSP: A new PET imaging agent for mapping Aβ plaques.

Yao X, Zha Z, Zhao R, Choi SR, Ploessl K, Liu F, Zhu L, Kung HF. Yao X, et al. Among authors: zhao r. Nucl Med Biol. 2019 Apr;71:54-64. doi: 10.1016/j.nucmedbio.2019.05.002. Epub 2019 May 16. Nucl Med Biol. 2019. PMID: 31152974

2

Developing a cassette microdosing approach to enhance the throughput of PET imaging agent screening.

Xiao H, Sun M, Zhao R, Hong H, Zhang A, Zhang S, Liu F, Zhang Y, Liu Y, Zhu L, Kung HF, Qiao J. Xiao H, et al. Among authors: zhao r. J Pharm Biomed Anal. 2018 May 30;154:48-56. doi: 10.1016/j.jpba.2018.02.063. Epub 2018 Mar 3. J Pharm Biomed Anal. 2018. PMID: 29533858

3

In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.

Zhang L, Yao X, Cao J, Hong H, Zhang A, Zhao R, Zhang Y, Zha Z, Liu Y, Qiao J, Zhu L, Kung HF. Zhang L, et al. Among authors: zhao r. Mol Pharm. 2019 Mar 4;16(3):1156-1166. doi: 10.1021/acs.molpharmaceut.8b01131. Epub 2019 Feb 20. Mol Pharm. 2019. PMID: 30676751

4

VMAT2 imaging agent, D6-[¹⁸F]FP-(+)-DTBZ: Improved radiosynthesis, purification by solid-phase extraction and characterization.

Zhao R, Zha Z, Yao X, Ploessl K, Choi SR, Liu F, Zhu L, Kung HF. Zhao R, et al. Nucl Med Biol. 2019 May-Jun;72-73:26-35. doi: 10.1016/j.nucmedbio.2019.07.002. Epub 2019 Jul 11. Nucl Med Biol. 2019. PMID: 31330409

5

Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer.

Yao X, Zha Z, Ploessl K, Choi SR, Zhao R, Alexoff D, Zhu L, Kung HF. Yao X, et al. Among authors: zhao r. Bioorg Med Chem. 2020 Mar 1;28(5):115319. doi: 10.1016/j.bmc.2020.115319. Epub 2020 Jan 20. Bioorg Med Chem. 2020. PMID: 32001090

6

Synthesis and Evaluation of ⁶⁸Ga- and ¹⁷⁷Lu-Labeled (R)- vs (S)-DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives.

Zhao R, Ploessl K, Zha Z, Choi S, Alexoff D, Zhu L, Kung HF. Zhao R, et al. Mol Pharm. 2020 Dec 7;17(12):4589-4602. doi: 10.1021/acs.molpharmaceut.0c00777. Epub 2020 Oct 27. Mol Pharm. 2020. PMID: 33108189

7

Radiolabeling Optimization and Preclinical Evaluation of the New PSMA Imaging Agent [¹⁸F]AlF-P16-093.

Zha Z, Choi SR, Ploessl K, Alexoff D, Zhao R, Zhu L, Kung HF. Zha Z, et al. Among authors: zhao r. Bioconjug Chem. 2021 May 19;32(5):1017-1026. doi: 10.1021/acs.bioconjchem.1c00177. Epub 2021 Apr 19. Bioconjug Chem. 2021. PMID: 33872489

8

A New Highly Deuterated [¹⁸F]AV-45, [¹⁸F]D15FSP, for Imaging β-Amyloid Plaques in the Brain.

Xiao H, Choi SR, Zhao R, Ploessl K, Alexoff D, Zhu L, Zha Z, Kung HF. Xiao H, et al. Among authors: zhao r. ACS Med Chem Lett. 2021 Jun 21;12(7):1086-1092. doi: 10.1021/acsmedchemlett.1c00062. eCollection 2021 Jul 8. ACS Med Chem Lett. 2021. PMID: 34267878 Free PMC article.

9

⁶⁸Ga-labelled-exendin-4: New GLP1R targeting agents for imaging pancreatic β-cell and insulinoma.

Li L, Zhao R, Hong H, Li G, Zhang Y, Luo Y, Zha Z, Zhu J, Qiao J, Zhu L, Kung HF. Li L, et al. Among authors: zhao r. Nucl Med Biol. 2021 Nov-Dec;102-103:87-96. doi: 10.1016/j.nucmedbio.2021.10.001. Epub 2021 Oct 9. Nucl Med Biol. 2021. PMID: 34695640

10

New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177).

Zha Z, Choi SR, Li L, Zhao R, Ploessl K, Yao X, Alexoff D, Zhu L, Kung HF. Zha Z, et al. Among authors: zhao r. J Med Chem. 2022 Oct 13;65(19):13001-13012. doi: 10.1021/acs.jmedchem.2c00852. Epub 2022 Sep 14. J Med Chem. 2022. PMID: 36103652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,440 results

Search Page

Filters